Synlogic, Inc. (NASDAQ:SYBX – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $1.16 and traded as low as $0.9750. Synlogic shares last traded at $1.00, with a volume of 639 shares traded.
Synlogic Price Performance
The firm has a fifty day simple moving average of $1.15 and a 200-day simple moving average of $0.88. The firm has a market cap of $12.25 million, a P/E ratio of -3.85 and a beta of 0.61.
Synlogic Company Profile
Synlogic, Inc was a clinical-stage biotechnology company focused on developing medicines based on synthetic biology. The company engineered probiotic bacteria, referred to as Synthetic Biotics, to perform specific therapeutic functions inside the gastrointestinal tract, such as metabolizing disease-associated compounds or producing beneficial molecules.
Its development programs targeted rare metabolic disorders, including phenylketonuria (PKU) and homocystinuria. Among its investigational candidates were SYNB1934 and the earlier SYNB1618 for PKU, as well as SYNB1353 for homocystinuria.
Further Reading
- Five stocks we like better than Synlogic
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Synlogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synlogic and related companies with MarketBeat.com's FREE daily email newsletter.
